表紙
市場調查報告書

全球女性不孕症診斷、治療市場調查、分析

Global Female Infertility Diagnosis And Treatment Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 505698
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
全球女性不孕症診斷、治療市場調查、分析 Global Female Infertility Diagnosis And Treatment Market 2019-2025
出版日期: 2019年10月24日內容資訊: 英文
簡介

本報告提供全球女性不孕症診斷、治療市場相關調查分析,市場影響要素,各市場區隔的市場分析,地區分析,競爭情形,以及主要企業的簡介等彙整。

第1章 調查摘要

第2章 市場概要、考察

  • 定義
  • 分析師的見解、目前市場趨勢
    • 主要調查結果
    • 建議
    • 結論
  • 法規
    • 美國
    • EU
    • 中國
    • 印度
    • 其他

第3章 市場決策要素

  • 推動因素
  • 阻礙因素
  • 機會

第4章 市場區隔

  • 全球女性不孕症市場:各診斷
    • 排卵檢驗市場
    • 輸卵管造影市場
    • 子宮鏡檢查市場
    • 影像檢查市場
    • 卵巢預備能力檢驗市場
    • 荷爾蒙等級檢驗市場
    • 遺傳基因檢驗市場
    • 其他
  • 全球女性不孕症市場:各治療
    • 藥物、醫藥市場
    • 外科手術市場
    • 人工授精 (IUI) 市場
    • 輔助生殖技術醫療 (ART) 市場
    • 其他

第5章 競爭情形

  • 主要策略分析
  • 主要企業分析

第6章 地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第7章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: OMR2019930

Title:
Global Female Infertility Diagnosis and Treatment
Market Size, Share & Trends Analysis Report by Diagnosis (Ovulation Testing, Ovarian Reserve Testing, Hormonal Level Testing, Hysterosalpingography (HSG), Hysteroscopy, Imaging Testing, Genetic Testing, and Others), by Treatment (Drugs, Surgery, Intrauterine Insemination (IUI), and ART), and by End-User (Hospitals and Clinics, Homecare, and Pathology and Diagnostic Centers) and Forecast 2019-2025.

The global female infertility diagnosis and treatment market is estimated to grow at a CAGR of 4% during the forecast period. Changing lifestyle and increasing the IVF market are the major factors propelling the growth of the global market. Furthermore, the rising trend of surrogacy, growing infertility rate among females, new technologies to avoid multiple embryo implants are also estimated to be the major factors that are contributing significantly towards the growth of the market. However, the high cost of infertility treatment, a low accuracy rate of the treatment, and social stigma related to the infertility treatment are the major constraints that are hindering the growth of the global market.

The global female infertility diagnosis and treatment market is segmented on the basis of diagnosis, treatment, and end-user. Based on the diagnosis, the market is segmented into the ovulation testing, ovarian reserve testing, hormonal level testing, hysterosalpingography (HSG), hysteroscopy, imaging testing, genetic testing, and others. Based on the diagnosis, the market is fragmented into drugs, surgery, IUI, and ART. Among the type of treatments, the ART segment is projected to witness considerable growth in the market due to the continuous advancements in the ART. The market is further analyzed on the basis of end-users of the female infertility diagnosis and treatment, including hospitals and clinics, homecare, and pathology and diagnostic centers.

The global female infertility diagnosis and treatment market is further segmented on the basis of geography, including North America, Europe, Asia-Pacific, and Rest of the World. North America is anticipated to hold a significant share in the global market, owing to the rising prevalence of hormonal disorders caused by changing lifestyle, excessive alcohol consumption, lack of exercise, and stress. As per the study of the University of Maryland Medical Center (UMMC), in the US, around 10% of women aged between 15 and 44 are having difficulties in getting pregnant or carrying the pregnancy to full term. Asia-Pacific is considered an emerging market for female infertility diagnosis and treatment, owing to the presence of developing economies, growing awareness about methods such as IUI and IVF, and increasing per capita health care spending in the region.

The major market player of the female infertility diagnosis and treatment market includes Bayer AG, Pfizer Inc., Church & Dwight Co., Inc., Vitrolife, Genea Ltd., Ferring B.V., and Millendo Therapeutics Inc. These players are actively adopting growth strategies such as mergers and acquisitions, partnerships, collaboration and agreements to enhance their geographical reach. Innovative product development and new product launching are the core strength of key market players in the female infertility diagnosis and treatment market. For instance, in March 2018, Vitrolife AB had received approval for the sale of its time-lapse incubator EmbryoScope in the US. Through this approval, the company expanded its product portfolio and market presence in the US infertility treatment market.

Research Methodology

The market study of the global female infertility diagnosis and treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for infertility market players, research institutes, laboratories, clinics, medical professionals, government agencies, and related industries for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • 1. Global Female Infertility Diagnosis and Treatment Market Research and Analysis by Diagnosis
  • 2. Global Female Infertility Diagnosis and Treatment Market Research and Analysis by Treatment
  • 3. Global Female Infertility Diagnosis and Treatment Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive Research Methodologyof the global female infertility diagnosis and treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global female infertility diagnosis and treatment market.
  • Insights about market determinants which are stimulating the global female infertility diagnosis and treatment market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Bayer AG
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Pfizer Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. FIRST RESPONSE, a division of Church & Dwight Co., Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Vitrolife
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Genea Ltd.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

4.1 Motivators

4.2 Restraints

4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Female Infertility Diagnosis and Treatment Market by Diagnosis
    • 5.1.1. Ovulation Testing
    • 5.1.2. Hysterosalpingography (HSG)
    • 5.1.3. Hysteroscopy
    • 5.1.4. Imaging Testing
    • 5.1.5. Ovarian Reserve Testing
    • 5.1.6. Hormonal Level Testing
    • 5.1.7. Genetic Testing
    • 5.1.8. Others (Laparoscopy)
  • 5.2. Global Female Infertility Diagnosis and Treatment Market by Treatment
    • 5.2.1. Drugs
    • 5.2.2. Surgery
    • 5.2.3. Intrauterine Insemination (IUI)
    • 5.2.4. Assisted Reproductive Technology (ART)
  • 5.3. Global Female Infertility Diagnosis and Treatment Market by End-User
    • 5.3.1. Hospitals and Clinics
    • 5.3.2. Homecare
    • 5.3.3. Pathology and Diagnostic Centers

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Bayer AG
  • 7.2. Clearblue, a company of SPD Swiss Precision Diagnostics GmbH
  • 7.3. Cook Medical, Inc.
  • 7.4. Eli Lilly & Co.
  • 7.5. Esco Group
  • 7.6. Fairhaven Health, LLC
  • 7.7. Ferring B.V.
  • 7.8. FIRST RESPONSE, a division of Church & Dwight Co., Inc.
  • 7.9. FUJIFILM Irvine Scientific, Inc.
  • 7.10. Genea Ltd.
  • 7.11. GlaxoSmithKline Plc.
  • 7.12. Merck KGaA
  • 7.13. Millendo Therapeutics Inc.
  • 7.14. Pfizer Inc.
  • 7.15. Vitrolife
  • 7.16. Princeton BioMeditech Corp.

LIST OF TABLES

  • 1. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • 2. GLOBAL OVULATION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL HYSTEROSALPINGOGRAPHY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL HYSTEROSCOPY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL IMAGING TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL OVARIAN RESERVE TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL HORMONAL LEVEL TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 11. GLOBAL DRUGS FOR FEMALE INFERTILITY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 12. GLOBAL SURGERY FOR FEMALE INFERTILITY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 13. GLOBAL INTRAUTERINE INSEMINATION (IUI) FOR FEMALE INFERTILITY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 14. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY (ART) FOR FEMALE INFERTILITY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 15. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 16. GLOBAL FEMALE INFERTILITY TREATMENT IN HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 17. GLOBAL FEMALE INFERTILITY TREATMENT IN HOMECARE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 18. GLOBAL FEMALE INFERTILITY IN PATHOLOGY AND DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 19. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY,2018-2025 ($ MILLION)
  • 20. NORTH AMERICAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 21. NORTH AMERICAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • 22. NORTH AMERICAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 23. NORTH AMERICAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 24. EUROPEAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 25. EUROPEAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • 26. EUROPEAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 27. EUROPEAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 28. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 29. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • 30. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 31. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 32. REST OF THE WORLD FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)
  • 33. REST OF THE WORLD FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 34. REST OF THE WORLD FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY DIAGNOSIS, 2018 VS 2025 (%)
  • 2. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY TREATMENT, 2018 VS 2025 (%)
  • 3. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY END-USER, 2018 VS 2025 (%)
  • 4. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 5. US FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. CANADA FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. UK FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. FRANCE FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. GERMANY FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. ITALY FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. SPAIN Portable Medical Electronic EQUIPMENT MARKET SIZE, 2018-2025 ($ MILLION)
Back to Top